• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.

作者信息

Hampel Paul J, Rabe Kari G, Wang Yucai, Hwang Steven R, Kenderian Saad S, Muchtar Eli, Leis Jose F, Koehler Amber B, Tsang Mazie, Hilal Talal, Parrondo Ricardo, Bailen Rachel J, Schwager Susan M, Hanson Curtis A, Braggio Esteban, Slager Susan L, Shi Min, Zepeda-Mendoza Cinthya J, Van Dyke Daniel L, Shanafelt Tait D, King Rebecca L, Call Timothy G, Kay Neil E, Ding Wei, Parikh Sameer A

机构信息

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

出版信息

Leukemia. 2025 Feb;39(2):503-507. doi: 10.1038/s41375-024-02492-4. Epub 2024 Dec 10.

DOI:10.1038/s41375-024-02492-4
PMID:39658628
Abstract
摘要

相似文献

1
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.靶向治疗时代慢性淋巴细胞白血病/小淋巴细胞淋巴瘤Richter转化的发生率。
Leukemia. 2025 Feb;39(2):503-507. doi: 10.1038/s41375-024-02492-4. Epub 2024 Dec 10.
2
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.慢性淋巴细胞白血病中的 Richter 综合征：生物学、临床特征及治疗的最新进展
Leuk Lymphoma. 2015 Jul;56(7):1949-58. doi: 10.3109/10428194.2014.979411. Epub 2015 Jan 21.
3
Life-Threatening Fungal Infection in Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Brief Review of Literature.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤Richter转化中的危及生命的真菌感染：一例报告并文献简要回顾
Cureus. 2021 Jun 25;13(6):e15924. doi: 10.7759/cureus.15924. eCollection 2021 Jun.
4
Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤和 B 细胞幼淋巴细胞白血病的进展和转化：来自 2021 年 SH/EAHP 研讨会的报告。
Am J Clin Pathol. 2023 Jun 1;159(6):554-571. doi: 10.1093/ajcp/aqad027.
5
Richter Transformation Arising From Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病引起的 Richter 转化。
Clin J Oncol Nurs. 2022 Feb 1;26(1):14-17. doi: 10.1188/22.CJON.14-17.
6
Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.Richter综合征伴慢性淋巴细胞白血病/小淋巴细胞淋巴瘤细胞的滤泡浸润，酷似滤泡性淋巴瘤。
Int J Surg Pathol. 2014 Dec;22(8):736-43. doi: 10.1177/1066896913509011. Epub 2013 Nov 18.
7
Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.新型疗法时代慢性淋巴细胞白血病Richter转化的治疗方法
Ann Hematol. 2018 Jan;97(1):1-15. doi: 10.1007/s00277-017-3149-9. Epub 2017 Oct 23.
8
Richter transformation in the era of novel agents.新型药物时代的 Richter 转化。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):256-263. doi: 10.1182/asheducation-2018.1.256.
9
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.慢性淋巴细胞白血病中的 Richter 转化：新型药物时代的进展
Cancers (Basel). 2021 Oct 14;13(20):5141. doi: 10.3390/cancers13205141.
10
Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.阿卡替尼单药治疗慢性淋巴细胞白血病（ACE-CL-001）：一项开放标签、单臂、1-2 期研究中 Richter 转化队列的分析。
Lancet Haematol. 2021 Dec;8(12):e912-e921. doi: 10.1016/S2352-3026(21)00305-7. Epub 2021 Nov 1.

引用本文的文献

1
Molecular Features Accompanying Richter's Transformation in Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病患者里氏转化伴随的分子特征
Int J Mol Sci. 2025 Jun 10;26(12):5563. doi: 10.3390/ijms26125563.
2
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies.惰性B细胞恶性肿瘤向侵袭性B细胞恶性肿瘤转变的分子机制
Cancers (Basel). 2025 Mar 6;17(5):907. doi: 10.3390/cancers17050907.

本文引用的文献

1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.初治慢性淋巴细胞白血病的维奈托克联合治疗方案。
N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093.
2
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.检测慢性淋巴细胞白血病中 Richter 转化的早期播种。
Nat Med. 2022 Aug;28(8):1662-1671. doi: 10.1038/s41591-022-01927-8. Epub 2022 Aug 11.
3
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.伊布替尼-利妥昔单抗与化疗免疫治疗慢性淋巴细胞白血病的长期疗效：E1912 试验的更新结果。
Blood. 2022 Jul 14;140(2):112-120. doi: 10.1182/blood.2021014960.
4
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.阿卡替尼联合或不联合奥滨尤妥珠单抗对比苯丁酸氮芥联合奥滨尤妥珠单抗治疗初治慢性淋巴细胞白血病（ELEVATE TN）：一项随机、对照、III 期临床试验。
Lancet. 2020 Apr 18;395(10232):1278-1291. doi: 10.1016/S0140-6736(20)30262-2.
5
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.慢性淋巴细胞白血病（CLL）中的 Richter 转化——德国 CLL 研究组（GCLLSG）一线治疗试验的汇总分析。
Leukemia. 2021 Jan;35(1):169-176. doi: 10.1038/s41375-020-0797-x. Epub 2020 Mar 17.
6
Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.挪威一项大型基于人群的慢性淋巴细胞白血病队列中 Richter 综合征的流行病学研究。
Cancer Epidemiol. 2019 Jun;60:128-133. doi: 10.1016/j.canep.2019.04.002. Epub 2019 Apr 12.
7
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.伊布替尼方案与化疗免疫治疗在未经治疗的老年 CLL 患者中的比较。
N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.
8
Biology and treatment of Richter syndrome.里希特综合征的生物学特性与治疗。
Blood. 2018 Jun 21;131(25):2761-2772. doi: 10.1182/blood-2018-01-791376. Epub 2018 Apr 24.
9
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.依鲁替尼治疗后慢性淋巴细胞白血病进展的临床病理特征和结局。
Blood. 2017 Jun 22;129(25):3362-3370. doi: 10.1182/blood-2017-01-763003. Epub 2017 May 4.
10
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.伊布替尼治疗中断的病因及慢性淋巴细胞白血病患者的结局。
JAMA Oncol. 2015 Apr;1(1):80-7. doi: 10.1001/jamaoncol.2014.218.